ACACA and ovarian carcinoma: An ACC allosteric inhibitor, 5-tetradecepoxy-2-furanoic acid (TOFA), regulates ovarian cancer proliferation and cell cycle progression, ACC1 has been regarded as an attractive therapeutic target for ovarian cancer.